Check out what we’ve been up to and where can we connect!
May 2, 2022
FHI Clinical Inc. announces today it will consult on the go-to-market strategy for COVID-19 related anti-inflammatory therapeutics for Gb Sciences. FHI Clinical will additionally write the draft clinical trial protocol for a first-in-human trial of these proprietary cannabinoid-containing formulations.
February 8, 2022
FHI Clinical Inc. announces today the official closing of its acquisition of the clinical trials business of Triclinium Clinical Development Proprietary Limited (TCD), a full-service, South Africa-based CRO. With the acquisition, FHI Clinical expands its share of the infectious disease (ID) clinical development market and becomes the dominant service provider in sub-Saharan Africa.
December 2, 2021
FHI Clinical announces its intent to acquire TCD Global, a South African-based CRO. The acquisition allows FHI Clinical to expand its share of the infectious disease (ID) clinical development market and become the dominant service provider in sub-Saharan Africa.
September 21, 2021
The results from this study provide important information about the clinical management of hospitalized patients with COVID-19. Additional research is needed to identify a method that can be used to accurately prioritize patients with COVID-19 at risk of critical illness or death.
Missed the webinar? View the recording to hear about Africa’s strong clinical research foundation, based on collaborative approaches with numerous stakeholders, complex studies with long-term follow-up and a community-centered approach to fostering enrollment and retention.
April 18-21, 2022
Attending the World Vaccine Congress 2022? Stop by our booth for a presentation about COVID-19 vaccine development, conducting trials in sub-Saharan Africa or using novel methods to ensure equitable access to clinical research. Members of our team will also be available to talk about our capabilities and services.
April 19, 2022
Join this roundtable, hosted by FHI Clinical, to discuss and compare experiences with COVID-19 and how those might be relevant when designing trials for other indications.
April 12, 2022
Join us for an episode of Careers in Pharma, a webinar featuring Daniel Joffe, Senior Clinical Project Manager at FHI Clinical, as he talks about his role as a project manager, challenges he faces and skills he uses.
March 17-19, 2022
At the 5th annual WAC-CREP conference, FHI Clinical employees are presenting findings from research being conducted within the Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL) network.
February 22, 2022
Join us for this plenary discussion in which experts in infectious diseases discuss how real-world epidemiology data, site capacity data and biosurveillance methodology could help identify TB-prevalent populations during protocol design, helping to ensure an adequate sample for TB vaccine development.
FHI Clinical Headquarters
359 Blackwell Street, Suite 200
Durham, NC 27701 USA